| Hans-Günter Meyer-Thompson | international
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19.
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19.
Davis CS, Samuels EA.
Int J Drug Policy. 2021 Jul;93:102905. doi: 10.1016/j.drugpo.2020.102905. Epub 2020 Aug 15. PMID: 32811685; PMCID: PMC7428767.